We initially demonstrated that upregulation of autophagy, using the mTOR inhibitor rapamycin or its water-soluble ester CCI-779, reduced levels of soluble and aggregated mutant huntingtin and was protective in cell, Drosophila and mouse models of Huntington's disease [14]. The gene discussed is HTT; the disease is Huntington disease.